nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—TERT—thyroid cancer	0.562	1	CbGaD
Zidovudine—UGT2B7—Epirubicin—thyroid cancer	0.0654	0.212	CbGbCtD
Zidovudine—ABCC4—Sorafenib—thyroid cancer	0.0506	0.164	CbGbCtD
Zidovudine—ABCG2—Vandetanib—thyroid cancer	0.0452	0.147	CbGbCtD
Zidovudine—ALB—Vandetanib—thyroid cancer	0.0311	0.101	CbGbCtD
Zidovudine—ABCG2—Sorafenib—thyroid cancer	0.0272	0.0884	CbGbCtD
Zidovudine—ABCG2—Doxorubicin—thyroid cancer	0.0165	0.0537	CbGbCtD
Zidovudine—CYP2C8—Sorafenib—thyroid cancer	0.0145	0.0471	CbGbCtD
Zidovudine—CYP2C19—Sorafenib—thyroid cancer	0.0122	0.0395	CbGbCtD
Zidovudine—CYP2C9—Sorafenib—thyroid cancer	0.0101	0.0329	CbGbCtD
Zidovudine—ABCB1—Sorafenib—thyroid cancer	0.00981	0.0319	CbGbCtD
Zidovudine—CYP3A4—Vandetanib—thyroid cancer	0.00975	0.0317	CbGbCtD
Zidovudine—ABCB1—Doxorubicin—thyroid cancer	0.00595	0.0193	CbGbCtD
Zidovudine—CYP3A4—Sorafenib—thyroid cancer	0.00588	0.0191	CbGbCtD
Zidovudine—CYP3A4—Doxorubicin—thyroid cancer	0.00357	0.0116	CbGbCtD
Zidovudine—Pruritus—Vandetanib—thyroid cancer	0.000232	0.00266	CcSEcCtD
Zidovudine—Musculoskeletal pain—Epirubicin—thyroid cancer	0.000232	0.00266	CcSEcCtD
Zidovudine—Arthralgia—Sorafenib—thyroid cancer	0.000231	0.00265	CcSEcCtD
Zidovudine—Myalgia—Sorafenib—thyroid cancer	0.000231	0.00265	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000229	0.00263	CcSEcCtD
Zidovudine—Hepatocellular injury—Epirubicin—thyroid cancer	0.000229	0.00263	CcSEcCtD
Zidovudine—Eructation—Epirubicin—thyroid cancer	0.000225	0.00258	CcSEcCtD
Zidovudine—Diarrhoea—Vandetanib—thyroid cancer	0.000225	0.00258	CcSEcCtD
Zidovudine—Cystitis noninfective—Epirubicin—thyroid cancer	0.000224	0.00257	CcSEcCtD
Zidovudine—Cystitis—Epirubicin—thyroid cancer	0.000222	0.00254	CcSEcCtD
Zidovudine—Anaphylactic shock—Sorafenib—thyroid cancer	0.000221	0.00254	CcSEcCtD
Zidovudine—Shock—Sorafenib—thyroid cancer	0.000218	0.0025	CcSEcCtD
Zidovudine—Fluid retention—Epirubicin—thyroid cancer	0.000218	0.0025	CcSEcCtD
Zidovudine—Nervous system disorder—Sorafenib—thyroid cancer	0.000217	0.00249	CcSEcCtD
Zidovudine—Dizziness—Vandetanib—thyroid cancer	0.000217	0.00249	CcSEcCtD
Zidovudine—Thrombocytopenia—Sorafenib—thyroid cancer	0.000217	0.00249	CcSEcCtD
Zidovudine—Aplastic anaemia—Epirubicin—thyroid cancer	0.000215	0.00247	CcSEcCtD
Zidovudine—Neuropathy—Epirubicin—thyroid cancer	0.000215	0.00247	CcSEcCtD
Zidovudine—Skin disorder—Sorafenib—thyroid cancer	0.000215	0.00247	CcSEcCtD
Zidovudine—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.000215	0.00246	CcSEcCtD
Zidovudine—Hepatocellular injury—Doxorubicin—thyroid cancer	0.000212	0.00243	CcSEcCtD
Zidovudine—Anorexia—Sorafenib—thyroid cancer	0.000211	0.00242	CcSEcCtD
Zidovudine—Vomiting—Vandetanib—thyroid cancer	0.000209	0.00239	CcSEcCtD
Zidovudine—Eructation—Doxorubicin—thyroid cancer	0.000209	0.00239	CcSEcCtD
Zidovudine—Rash maculo-papular—Epirubicin—thyroid cancer	0.000209	0.00239	CcSEcCtD
Zidovudine—Bladder pain—Epirubicin—thyroid cancer	0.000207	0.00238	CcSEcCtD
Zidovudine—Mouth ulceration—Epirubicin—thyroid cancer	0.000207	0.00238	CcSEcCtD
Zidovudine—Cystitis noninfective—Doxorubicin—thyroid cancer	0.000207	0.00238	CcSEcCtD
Zidovudine—Rash—Vandetanib—thyroid cancer	0.000207	0.00237	CcSEcCtD
Zidovudine—Dermatitis—Vandetanib—thyroid cancer	0.000207	0.00237	CcSEcCtD
Zidovudine—Headache—Vandetanib—thyroid cancer	0.000206	0.00236	CcSEcCtD
Zidovudine—Cystitis—Doxorubicin—thyroid cancer	0.000205	0.00235	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000202	0.00231	CcSEcCtD
Zidovudine—Fluid retention—Doxorubicin—thyroid cancer	0.000202	0.00231	CcSEcCtD
Zidovudine—Aplastic anaemia—Doxorubicin—thyroid cancer	0.000199	0.00229	CcSEcCtD
Zidovudine—Neuropathy—Doxorubicin—thyroid cancer	0.000199	0.00229	CcSEcCtD
Zidovudine—Dyspnoea—Sorafenib—thyroid cancer	0.000197	0.00226	CcSEcCtD
Zidovudine—Lymphadenopathy—Epirubicin—thyroid cancer	0.000195	0.00224	CcSEcCtD
Zidovudine—Nausea—Vandetanib—thyroid cancer	0.000195	0.00224	CcSEcCtD
Zidovudine—Dyspepsia—Sorafenib—thyroid cancer	0.000195	0.00224	CcSEcCtD
Zidovudine—Phlebitis—Epirubicin—thyroid cancer	0.000193	0.00222	CcSEcCtD
Zidovudine—Rash maculo-papular—Doxorubicin—thyroid cancer	0.000193	0.00221	CcSEcCtD
Zidovudine—Decreased appetite—Sorafenib—thyroid cancer	0.000193	0.00221	CcSEcCtD
Zidovudine—Bladder pain—Doxorubicin—thyroid cancer	0.000192	0.0022	CcSEcCtD
Zidovudine—Mouth ulceration—Doxorubicin—thyroid cancer	0.000192	0.0022	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000191	0.00219	CcSEcCtD
Zidovudine—Fatigue—Sorafenib—thyroid cancer	0.000191	0.00219	CcSEcCtD
Zidovudine—Constipation—Sorafenib—thyroid cancer	0.000189	0.00217	CcSEcCtD
Zidovudine—Pain—Sorafenib—thyroid cancer	0.000189	0.00217	CcSEcCtD
Zidovudine—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000184	0.00211	CcSEcCtD
Zidovudine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000181	0.00208	CcSEcCtD
Zidovudine—Lymphadenopathy—Doxorubicin—thyroid cancer	0.000181	0.00207	CcSEcCtD
Zidovudine—Phlebitis—Doxorubicin—thyroid cancer	0.000179	0.00205	CcSEcCtD
Zidovudine—Urticaria—Sorafenib—thyroid cancer	0.000176	0.00202	CcSEcCtD
Zidovudine—Abdominal pain—Sorafenib—thyroid cancer	0.000175	0.00201	CcSEcCtD
Zidovudine—Body temperature increased—Sorafenib—thyroid cancer	0.000175	0.00201	CcSEcCtD
Zidovudine—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00017	0.00195	CcSEcCtD
Zidovudine—Affect lability—Epirubicin—thyroid cancer	0.000164	0.00188	CcSEcCtD
Zidovudine—Asthenia—Sorafenib—thyroid cancer	0.000159	0.00182	CcSEcCtD
Zidovudine—Mood swings—Epirubicin—thyroid cancer	0.000158	0.00181	CcSEcCtD
Zidovudine—Pruritus—Sorafenib—thyroid cancer	0.000157	0.0018	CcSEcCtD
Zidovudine—Affect lability—Doxorubicin—thyroid cancer	0.000152	0.00174	CcSEcCtD
Zidovudine—Diarrhoea—Sorafenib—thyroid cancer	0.000152	0.00174	CcSEcCtD
Zidovudine—Breast disorder—Epirubicin—thyroid cancer	0.000151	0.00173	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00015	0.00172	CcSEcCtD
Zidovudine—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00015	0.00172	CcSEcCtD
Zidovudine—Nasopharyngitis—Epirubicin—thyroid cancer	0.000149	0.00171	CcSEcCtD
Zidovudine—Dizziness—Sorafenib—thyroid cancer	0.000146	0.00168	CcSEcCtD
Zidovudine—Mood swings—Doxorubicin—thyroid cancer	0.000146	0.00167	CcSEcCtD
Zidovudine—Influenza—Epirubicin—thyroid cancer	0.000144	0.00165	CcSEcCtD
Zidovudine—Dysphagia—Epirubicin—thyroid cancer	0.000144	0.00165	CcSEcCtD
Zidovudine—Pancreatitis—Epirubicin—thyroid cancer	0.000141	0.00162	CcSEcCtD
Zidovudine—Vomiting—Sorafenib—thyroid cancer	0.000141	0.00161	CcSEcCtD
Zidovudine—Rash—Sorafenib—thyroid cancer	0.00014	0.0016	CcSEcCtD
Zidovudine—Dermatitis—Sorafenib—thyroid cancer	0.00014	0.0016	CcSEcCtD
Zidovudine—Breast disorder—Doxorubicin—thyroid cancer	0.000139	0.0016	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000139	0.00159	CcSEcCtD
Zidovudine—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000139	0.00159	CcSEcCtD
Zidovudine—Headache—Sorafenib—thyroid cancer	0.000139	0.00159	CcSEcCtD
Zidovudine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000138	0.00158	CcSEcCtD
Zidovudine—Pancytopenia—Epirubicin—thyroid cancer	0.000137	0.00157	CcSEcCtD
Zidovudine—Dysuria—Epirubicin—thyroid cancer	0.000135	0.00154	CcSEcCtD
Zidovudine—Neutropenia—Epirubicin—thyroid cancer	0.000135	0.00154	CcSEcCtD
Zidovudine—Influenza—Doxorubicin—thyroid cancer	0.000133	0.00153	CcSEcCtD
Zidovudine—Dysphagia—Doxorubicin—thyroid cancer	0.000133	0.00153	CcSEcCtD
Zidovudine—Pollakiuria—Epirubicin—thyroid cancer	0.000133	0.00152	CcSEcCtD
Zidovudine—Nausea—Sorafenib—thyroid cancer	0.000132	0.00151	CcSEcCtD
Zidovudine—Pancreatitis—Doxorubicin—thyroid cancer	0.000131	0.0015	CcSEcCtD
Zidovudine—Weight decreased—Epirubicin—thyroid cancer	0.00013	0.00149	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000127	0.00146	CcSEcCtD
Zidovudine—Pancytopenia—Doxorubicin—thyroid cancer	0.000126	0.00145	CcSEcCtD
Zidovudine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000126	0.00144	CcSEcCtD
Zidovudine—Jaundice—Epirubicin—thyroid cancer	0.000125	0.00143	CcSEcCtD
Zidovudine—Stomatitis—Epirubicin—thyroid cancer	0.000125	0.00143	CcSEcCtD
Zidovudine—Neutropenia—Doxorubicin—thyroid cancer	0.000125	0.00143	CcSEcCtD
Zidovudine—Dysuria—Doxorubicin—thyroid cancer	0.000125	0.00143	CcSEcCtD
Zidovudine—Sweating—Epirubicin—thyroid cancer	0.000123	0.00141	CcSEcCtD
Zidovudine—Pollakiuria—Doxorubicin—thyroid cancer	0.000123	0.00141	CcSEcCtD
Zidovudine—Haematuria—Epirubicin—thyroid cancer	0.000122	0.0014	CcSEcCtD
Zidovudine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000121	0.00139	CcSEcCtD
Zidovudine—Epistaxis—Epirubicin—thyroid cancer	0.000121	0.00139	CcSEcCtD
Zidovudine—Weight decreased—Doxorubicin—thyroid cancer	0.00012	0.00138	CcSEcCtD
Zidovudine—Sinusitis—Epirubicin—thyroid cancer	0.00012	0.00138	CcSEcCtD
Zidovudine—Agranulocytosis—Epirubicin—thyroid cancer	0.00012	0.00137	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000118	0.00135	CcSEcCtD
Zidovudine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000116	0.00133	CcSEcCtD
Zidovudine—Jaundice—Doxorubicin—thyroid cancer	0.000116	0.00133	CcSEcCtD
Zidovudine—Stomatitis—Doxorubicin—thyroid cancer	0.000116	0.00133	CcSEcCtD
Zidovudine—Rhinitis—Epirubicin—thyroid cancer	0.000116	0.00132	CcSEcCtD
Zidovudine—Hepatitis—Epirubicin—thyroid cancer	0.000115	0.00132	CcSEcCtD
Zidovudine—Pharyngitis—Epirubicin—thyroid cancer	0.000114	0.00131	CcSEcCtD
Zidovudine—Sweating—Doxorubicin—thyroid cancer	0.000114	0.00131	CcSEcCtD
Zidovudine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000114	0.0013	CcSEcCtD
Zidovudine—Haematuria—Doxorubicin—thyroid cancer	0.000113	0.0013	CcSEcCtD
Zidovudine—Connective tissue disorder—Epirubicin—thyroid cancer	0.000113	0.0013	CcSEcCtD
Zidovudine—Urethral disorder—Epirubicin—thyroid cancer	0.000113	0.00129	CcSEcCtD
Zidovudine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000112	0.00129	CcSEcCtD
Zidovudine—Epistaxis—Doxorubicin—thyroid cancer	0.000112	0.00128	CcSEcCtD
Zidovudine—Sinusitis—Doxorubicin—thyroid cancer	0.000111	0.00128	CcSEcCtD
Zidovudine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000111	0.00127	CcSEcCtD
Zidovudine—Erythema multiforme—Epirubicin—thyroid cancer	0.000109	0.00125	CcSEcCtD
Zidovudine—Cardiac disorder—Epirubicin—thyroid cancer	0.000107	0.00123	CcSEcCtD
Zidovudine—Rhinitis—Doxorubicin—thyroid cancer	0.000107	0.00123	CcSEcCtD
Zidovudine—Hepatitis—Doxorubicin—thyroid cancer	0.000107	0.00122	CcSEcCtD
Zidovudine—Pharyngitis—Doxorubicin—thyroid cancer	0.000106	0.00121	CcSEcCtD
Zidovudine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000105	0.00121	CcSEcCtD
Zidovudine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000105	0.0012	CcSEcCtD
Zidovudine—Urethral disorder—Doxorubicin—thyroid cancer	0.000105	0.0012	CcSEcCtD
Zidovudine—Mediastinal disorder—Epirubicin—thyroid cancer	0.000104	0.00119	CcSEcCtD
Zidovudine—Chills—Epirubicin—thyroid cancer	0.000103	0.00119	CcSEcCtD
Zidovudine—Mental disorder—Epirubicin—thyroid cancer	0.000101	0.00116	CcSEcCtD
Zidovudine—Erythema multiforme—Doxorubicin—thyroid cancer	0.000101	0.00116	CcSEcCtD
Zidovudine—Erythema—Epirubicin—thyroid cancer	0.0001	0.00115	CcSEcCtD
Zidovudine—Malnutrition—Epirubicin—thyroid cancer	0.0001	0.00115	CcSEcCtD
Zidovudine—Cardiac disorder—Doxorubicin—thyroid cancer	9.89e-05	0.00113	CcSEcCtD
Zidovudine—Flatulence—Epirubicin—thyroid cancer	9.88e-05	0.00113	CcSEcCtD
Zidovudine—Tension—Epirubicin—thyroid cancer	9.84e-05	0.00113	CcSEcCtD
Zidovudine—Dysgeusia—Epirubicin—thyroid cancer	9.82e-05	0.00113	CcSEcCtD
Zidovudine—Nervousness—Epirubicin—thyroid cancer	9.74e-05	0.00112	CcSEcCtD
Zidovudine—Back pain—Epirubicin—thyroid cancer	9.7e-05	0.00111	CcSEcCtD
Zidovudine—Muscle spasms—Epirubicin—thyroid cancer	9.64e-05	0.00111	CcSEcCtD
Zidovudine—Mediastinal disorder—Doxorubicin—thyroid cancer	9.61e-05	0.0011	CcSEcCtD
Zidovudine—Chills—Doxorubicin—thyroid cancer	9.57e-05	0.0011	CcSEcCtD
Zidovudine—Mental disorder—Doxorubicin—thyroid cancer	9.34e-05	0.00107	CcSEcCtD
Zidovudine—Ill-defined disorder—Epirubicin—thyroid cancer	9.31e-05	0.00107	CcSEcCtD
Zidovudine—Erythema—Doxorubicin—thyroid cancer	9.28e-05	0.00106	CcSEcCtD
Zidovudine—Malnutrition—Doxorubicin—thyroid cancer	9.28e-05	0.00106	CcSEcCtD
Zidovudine—Anaemia—Epirubicin—thyroid cancer	9.27e-05	0.00106	CcSEcCtD
Zidovudine—Flatulence—Doxorubicin—thyroid cancer	9.14e-05	0.00105	CcSEcCtD
Zidovudine—Tension—Doxorubicin—thyroid cancer	9.11e-05	0.00104	CcSEcCtD
Zidovudine—Dysgeusia—Doxorubicin—thyroid cancer	9.09e-05	0.00104	CcSEcCtD
Zidovudine—Malaise—Epirubicin—thyroid cancer	9.04e-05	0.00104	CcSEcCtD
Zidovudine—Nervousness—Doxorubicin—thyroid cancer	9.01e-05	0.00103	CcSEcCtD
Zidovudine—Vertigo—Epirubicin—thyroid cancer	9.01e-05	0.00103	CcSEcCtD
Zidovudine—Syncope—Epirubicin—thyroid cancer	8.99e-05	0.00103	CcSEcCtD
Zidovudine—Leukopenia—Epirubicin—thyroid cancer	8.98e-05	0.00103	CcSEcCtD
Zidovudine—Back pain—Doxorubicin—thyroid cancer	8.98e-05	0.00103	CcSEcCtD
Zidovudine—Muscle spasms—Doxorubicin—thyroid cancer	8.92e-05	0.00102	CcSEcCtD
Zidovudine—Loss of consciousness—Epirubicin—thyroid cancer	8.82e-05	0.00101	CcSEcCtD
Zidovudine—Cough—Epirubicin—thyroid cancer	8.75e-05	0.001	CcSEcCtD
Zidovudine—Convulsion—Epirubicin—thyroid cancer	8.69e-05	0.000996	CcSEcCtD
Zidovudine—Ill-defined disorder—Doxorubicin—thyroid cancer	8.61e-05	0.000987	CcSEcCtD
Zidovudine—Anaemia—Doxorubicin—thyroid cancer	8.58e-05	0.000983	CcSEcCtD
Zidovudine—Arthralgia—Epirubicin—thyroid cancer	8.54e-05	0.000979	CcSEcCtD
Zidovudine—Myalgia—Epirubicin—thyroid cancer	8.54e-05	0.000979	CcSEcCtD
Zidovudine—Chest pain—Epirubicin—thyroid cancer	8.54e-05	0.000979	CcSEcCtD
Zidovudine—Anxiety—Epirubicin—thyroid cancer	8.51e-05	0.000976	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	8.48e-05	0.000972	CcSEcCtD
Zidovudine—Discomfort—Epirubicin—thyroid cancer	8.44e-05	0.000967	CcSEcCtD
Zidovudine—Malaise—Doxorubicin—thyroid cancer	8.37e-05	0.00096	CcSEcCtD
Zidovudine—Vertigo—Doxorubicin—thyroid cancer	8.34e-05	0.000956	CcSEcCtD
Zidovudine—Syncope—Doxorubicin—thyroid cancer	8.32e-05	0.000954	CcSEcCtD
Zidovudine—Leukopenia—Doxorubicin—thyroid cancer	8.31e-05	0.000952	CcSEcCtD
Zidovudine—Confusional state—Epirubicin—thyroid cancer	8.25e-05	0.000946	CcSEcCtD
Zidovudine—Oedema—Epirubicin—thyroid cancer	8.19e-05	0.000939	CcSEcCtD
Zidovudine—Anaphylactic shock—Epirubicin—thyroid cancer	8.19e-05	0.000939	CcSEcCtD
Zidovudine—Loss of consciousness—Doxorubicin—thyroid cancer	8.16e-05	0.000935	CcSEcCtD
Zidovudine—Cough—Doxorubicin—thyroid cancer	8.1e-05	0.000928	CcSEcCtD
Zidovudine—Shock—Epirubicin—thyroid cancer	8.05e-05	0.000923	CcSEcCtD
Zidovudine—Convulsion—Doxorubicin—thyroid cancer	8.04e-05	0.000922	CcSEcCtD
Zidovudine—Nervous system disorder—Epirubicin—thyroid cancer	8.03e-05	0.00092	CcSEcCtD
Zidovudine—Thrombocytopenia—Epirubicin—thyroid cancer	8.01e-05	0.000919	CcSEcCtD
Zidovudine—Skin disorder—Epirubicin—thyroid cancer	7.95e-05	0.000912	CcSEcCtD
Zidovudine—Hyperhidrosis—Epirubicin—thyroid cancer	7.91e-05	0.000907	CcSEcCtD
Zidovudine—Chest pain—Doxorubicin—thyroid cancer	7.9e-05	0.000906	CcSEcCtD
Zidovudine—Myalgia—Doxorubicin—thyroid cancer	7.9e-05	0.000906	CcSEcCtD
Zidovudine—Arthralgia—Doxorubicin—thyroid cancer	7.9e-05	0.000906	CcSEcCtD
Zidovudine—Anxiety—Doxorubicin—thyroid cancer	7.87e-05	0.000903	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	7.85e-05	0.0009	CcSEcCtD
Zidovudine—Discomfort—Doxorubicin—thyroid cancer	7.81e-05	0.000895	CcSEcCtD
Zidovudine—Anorexia—Epirubicin—thyroid cancer	7.8e-05	0.000895	CcSEcCtD
Zidovudine—Confusional state—Doxorubicin—thyroid cancer	7.64e-05	0.000876	CcSEcCtD
Zidovudine—Anaphylactic shock—Doxorubicin—thyroid cancer	7.57e-05	0.000868	CcSEcCtD
Zidovudine—Oedema—Doxorubicin—thyroid cancer	7.57e-05	0.000868	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	7.46e-05	0.000855	CcSEcCtD
Zidovudine—Shock—Doxorubicin—thyroid cancer	7.45e-05	0.000854	CcSEcCtD
Zidovudine—Nervous system disorder—Doxorubicin—thyroid cancer	7.43e-05	0.000852	CcSEcCtD
Zidovudine—Thrombocytopenia—Doxorubicin—thyroid cancer	7.42e-05	0.00085	CcSEcCtD
Zidovudine—Insomnia—Epirubicin—thyroid cancer	7.4e-05	0.000849	CcSEcCtD
Zidovudine—Skin disorder—Doxorubicin—thyroid cancer	7.36e-05	0.000843	CcSEcCtD
Zidovudine—Paraesthesia—Epirubicin—thyroid cancer	7.35e-05	0.000843	CcSEcCtD
Zidovudine—Hyperhidrosis—Doxorubicin—thyroid cancer	7.32e-05	0.000839	CcSEcCtD
Zidovudine—Dyspnoea—Epirubicin—thyroid cancer	7.3e-05	0.000837	CcSEcCtD
Zidovudine—Somnolence—Epirubicin—thyroid cancer	7.28e-05	0.000834	CcSEcCtD
Zidovudine—Anorexia—Doxorubicin—thyroid cancer	7.22e-05	0.000828	CcSEcCtD
Zidovudine—Dyspepsia—Epirubicin—thyroid cancer	7.21e-05	0.000826	CcSEcCtD
Zidovudine—Decreased appetite—Epirubicin—thyroid cancer	7.12e-05	0.000816	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Epirubicin—thyroid cancer	7.07e-05	0.00081	CcSEcCtD
Zidovudine—Fatigue—Epirubicin—thyroid cancer	7.06e-05	0.000809	CcSEcCtD
Zidovudine—Pain—Epirubicin—thyroid cancer	7e-05	0.000803	CcSEcCtD
Zidovudine—Constipation—Epirubicin—thyroid cancer	7e-05	0.000803	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	6.9e-05	0.000791	CcSEcCtD
Zidovudine—Insomnia—Doxorubicin—thyroid cancer	6.85e-05	0.000785	CcSEcCtD
Zidovudine—Paraesthesia—Doxorubicin—thyroid cancer	6.8e-05	0.00078	CcSEcCtD
Zidovudine—Dyspnoea—Doxorubicin—thyroid cancer	6.75e-05	0.000774	CcSEcCtD
Zidovudine—Feeling abnormal—Epirubicin—thyroid cancer	6.75e-05	0.000773	CcSEcCtD
Zidovudine—Somnolence—Doxorubicin—thyroid cancer	6.73e-05	0.000772	CcSEcCtD
Zidovudine—Gastrointestinal pain—Epirubicin—thyroid cancer	6.69e-05	0.000767	CcSEcCtD
Zidovudine—Dyspepsia—Doxorubicin—thyroid cancer	6.67e-05	0.000764	CcSEcCtD
Zidovudine—Decreased appetite—Doxorubicin—thyroid cancer	6.58e-05	0.000755	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	6.54e-05	0.00075	CcSEcCtD
Zidovudine—Fatigue—Doxorubicin—thyroid cancer	6.53e-05	0.000749	CcSEcCtD
Zidovudine—Urticaria—Epirubicin—thyroid cancer	6.5e-05	0.000746	CcSEcCtD
Zidovudine—Pain—Doxorubicin—thyroid cancer	6.48e-05	0.000743	CcSEcCtD
Zidovudine—Constipation—Doxorubicin—thyroid cancer	6.48e-05	0.000743	CcSEcCtD
Zidovudine—Abdominal pain—Epirubicin—thyroid cancer	6.47e-05	0.000742	CcSEcCtD
Zidovudine—Body temperature increased—Epirubicin—thyroid cancer	6.47e-05	0.000742	CcSEcCtD
Zidovudine—Feeling abnormal—Doxorubicin—thyroid cancer	6.24e-05	0.000716	CcSEcCtD
Zidovudine—Gastrointestinal pain—Doxorubicin—thyroid cancer	6.19e-05	0.00071	CcSEcCtD
Zidovudine—Urticaria—Doxorubicin—thyroid cancer	6.02e-05	0.00069	CcSEcCtD
Zidovudine—Abdominal pain—Doxorubicin—thyroid cancer	5.99e-05	0.000686	CcSEcCtD
Zidovudine—Body temperature increased—Doxorubicin—thyroid cancer	5.99e-05	0.000686	CcSEcCtD
Zidovudine—Asthenia—Epirubicin—thyroid cancer	5.87e-05	0.000673	CcSEcCtD
Zidovudine—Pruritus—Epirubicin—thyroid cancer	5.79e-05	0.000664	CcSEcCtD
Zidovudine—Diarrhoea—Epirubicin—thyroid cancer	5.6e-05	0.000642	CcSEcCtD
Zidovudine—Asthenia—Doxorubicin—thyroid cancer	5.43e-05	0.000623	CcSEcCtD
Zidovudine—Dizziness—Epirubicin—thyroid cancer	5.41e-05	0.000621	CcSEcCtD
Zidovudine—Pruritus—Doxorubicin—thyroid cancer	5.36e-05	0.000614	CcSEcCtD
Zidovudine—Vomiting—Epirubicin—thyroid cancer	5.2e-05	0.000597	CcSEcCtD
Zidovudine—Diarrhoea—Doxorubicin—thyroid cancer	5.18e-05	0.000594	CcSEcCtD
Zidovudine—Rash—Epirubicin—thyroid cancer	5.16e-05	0.000592	CcSEcCtD
Zidovudine—Dermatitis—Epirubicin—thyroid cancer	5.16e-05	0.000591	CcSEcCtD
Zidovudine—Headache—Epirubicin—thyroid cancer	5.13e-05	0.000588	CcSEcCtD
Zidovudine—Dizziness—Doxorubicin—thyroid cancer	5.01e-05	0.000574	CcSEcCtD
Zidovudine—Nausea—Epirubicin—thyroid cancer	4.86e-05	0.000557	CcSEcCtD
Zidovudine—Vomiting—Doxorubicin—thyroid cancer	4.82e-05	0.000552	CcSEcCtD
Zidovudine—Rash—Doxorubicin—thyroid cancer	4.78e-05	0.000548	CcSEcCtD
Zidovudine—Dermatitis—Doxorubicin—thyroid cancer	4.77e-05	0.000547	CcSEcCtD
Zidovudine—Headache—Doxorubicin—thyroid cancer	4.74e-05	0.000544	CcSEcCtD
Zidovudine—Nausea—Doxorubicin—thyroid cancer	4.5e-05	0.000516	CcSEcCtD
Zidovudine—TERT—Signaling Pathways—CDK1—thyroid cancer	4.41e-05	0.00102	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—HPGD—thyroid cancer	4.4e-05	0.00102	CbGpPWpGaD
Zidovudine—TERT—Signaling by Wnt—AKT1—thyroid cancer	4.38e-05	0.00102	CbGpPWpGaD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.36e-05	0.00101	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.34e-05	0.00101	CbGpPWpGaD
Zidovudine—TERT—Disease—HIF1A—thyroid cancer	4.34e-05	0.00101	CbGpPWpGaD
Zidovudine—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	4.32e-05	0.001	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—MINPP1—thyroid cancer	4.28e-05	0.000993	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	4.23e-05	0.000982	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	4.2e-05	0.000976	CbGpPWpGaD
Zidovudine—ABCC5—Disease—TPR—thyroid cancer	4.09e-05	0.00095	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PRKAR1A—thyroid cancer	4.03e-05	0.000935	CbGpPWpGaD
Zidovudine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	4.02e-05	0.000933	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—NDUFA13—thyroid cancer	4e-05	0.000929	CbGpPWpGaD
Zidovudine—CYP2C8—Biological oxidations—RXRA—thyroid cancer	3.98e-05	0.000923	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—NDUFA13—thyroid cancer	3.96e-05	0.00092	CbGpPWpGaD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.96e-05	0.00092	CbGpPWpGaD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.96e-05	0.000919	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MEN1—thyroid cancer	3.85e-05	0.000893	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—IFNA2—thyroid cancer	3.82e-05	0.000887	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.8e-05	0.000882	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	3.77e-05	0.000876	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CHST14—thyroid cancer	3.76e-05	0.000874	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CHST14—thyroid cancer	3.72e-05	0.000865	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	3.72e-05	0.000864	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	3.72e-05	0.000864	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—CP—thyroid cancer	3.68e-05	0.000855	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—TPR—thyroid cancer	3.68e-05	0.000855	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.66e-05	0.00085	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—NDUFA13—thyroid cancer	3.64e-05	0.000844	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.62e-05	0.000841	CbGpPWpGaD
Zidovudine—TERT—Disease—BRAF—thyroid cancer	3.6e-05	0.000835	CbGpPWpGaD
Zidovudine—CYP2C19—Biological oxidations—RXRA—thyroid cancer	3.55e-05	0.000824	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—NRG1—thyroid cancer	3.54e-05	0.000822	CbGpPWpGaD
Zidovudine—SLC22A2—Transmission across Chemical Synapses—BRAF—thyroid cancer	3.46e-05	0.000803	CbGpPWpGaD
Zidovudine—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	3.44e-05	0.000799	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	3.44e-05	0.000799	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—TPR—thyroid cancer	3.43e-05	0.000796	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CHST14—thyroid cancer	3.42e-05	0.000794	CbGpPWpGaD
Zidovudine—TK1—Metabolism—PPARG—thyroid cancer	3.42e-05	0.000794	CbGpPWpGaD
Zidovudine—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	3.38e-05	0.000785	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PRKAR1A—thyroid cancer	3.37e-05	0.000783	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—TP53—thyroid cancer	3.37e-05	0.000782	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	3.36e-05	0.000779	CbGpPWpGaD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.33e-05	0.000773	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.31e-05	0.000768	CbGpPWpGaD
Zidovudine—CYP2C9—Biological oxidations—RXRA—thyroid cancer	3.24e-05	0.000751	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.19e-05	0.000741	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	3.19e-05	0.00074	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CALCA—thyroid cancer	3.06e-05	0.000711	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—HIF1A—thyroid cancer	3.04e-05	0.000706	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—HPGD—thyroid cancer	3.03e-05	0.000704	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—HPGD—thyroid cancer	3e-05	0.000697	CbGpPWpGaD
Zidovudine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	2.94e-05	0.000682	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—MINPP1—thyroid cancer	2.92e-05	0.000678	CbGpPWpGaD
Zidovudine—ALB—Metabolism—MINPP1—thyroid cancer	2.9e-05	0.000674	CbGpPWpGaD
Zidovudine—TERT—Disease—PTGS2—thyroid cancer	2.9e-05	0.000674	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.78e-05	0.000647	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.78e-05	0.000645	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CDK1—thyroid cancer	2.77e-05	0.000644	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—HPGD—thyroid cancer	2.76e-05	0.00064	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.76e-05	0.00064	CbGpPWpGaD
Zidovudine—TK1—Metabolism—PTGS2—thyroid cancer	2.69e-05	0.000625	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—BRAF—thyroid cancer	2.65e-05	0.000615	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PRKAR1A—thyroid cancer	2.61e-05	0.000606	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—MINPP1—thyroid cancer	2.61e-05	0.000605	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—SLC5A5—thyroid cancer	2.57e-05	0.000596	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—MINPP1—thyroid cancer	2.55e-05	0.000591	CbGpPWpGaD
Zidovudine—TERT—Disease—PTEN—thyroid cancer	2.53e-05	0.000588	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—TPR—thyroid cancer	2.53e-05	0.000587	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—BRAF—thyroid cancer	2.52e-05	0.000585	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—TP53—thyroid cancer	2.52e-05	0.000584	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PRKAR1A—thyroid cancer	2.49e-05	0.000577	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—NDUFA13—thyroid cancer	2.48e-05	0.000577	CbGpPWpGaD
Zidovudine—ALB—Metabolism—NDUFA13—thyroid cancer	2.47e-05	0.000573	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—MINPP1—thyroid cancer	2.38e-05	0.000552	CbGpPWpGaD
Zidovudine—TK1—Metabolism—PTEN—thyroid cancer	2.35e-05	0.000545	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.34e-05	0.000543	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CHST14—thyroid cancer	2.34e-05	0.000542	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CHST14—thyroid cancer	2.32e-05	0.000539	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.32e-05	0.000538	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	2.3e-05	0.000533	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	2.3e-05	0.000533	CbGpPWpGaD
Zidovudine—TERT—Disease—NRAS—thyroid cancer	2.26e-05	0.000525	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.26e-05	0.000524	CbGpPWpGaD
Zidovudine—ABCC5—Disease—NRG1—thyroid cancer	2.23e-05	0.000517	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—NDUFA13—thyroid cancer	2.22e-05	0.000515	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—NDUFA13—thyroid cancer	2.16e-05	0.000502	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—RXRA—thyroid cancer	2.16e-05	0.000501	CbGpPWpGaD
Zidovudine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	2.13e-05	0.000496	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CHST14—thyroid cancer	2.08e-05	0.000484	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CHST14—thyroid cancer	2.03e-05	0.000472	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—NDUFA13—thyroid cancer	2.02e-05	0.000469	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	2.01e-05	0.000467	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	2.01e-05	0.000467	CbGpPWpGaD
Zidovudine—ABCC5—Disease—TERT—thyroid cancer	2e-05	0.000464	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.98e-05	0.000459	CbGpPWpGaD
Zidovudine—TERT—Disease—KRAS—thyroid cancer	1.95e-05	0.000452	CbGpPWpGaD
Zidovudine—ABCC5—Disease—HIF1A—thyroid cancer	1.91e-05	0.000444	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CHST14—thyroid cancer	1.9e-05	0.000441	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—SLC5A5—thyroid cancer	1.89e-05	0.000439	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—HPGD—thyroid cancer	1.88e-05	0.000437	CbGpPWpGaD
Zidovudine—ALB—Metabolism—HPGD—thyroid cancer	1.87e-05	0.000435	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	1.86e-05	0.000432	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CCND1—thyroid cancer	1.84e-05	0.000427	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.78e-05	0.000414	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—PTEN—thyroid cancer	1.77e-05	0.000412	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—TPR—thyroid cancer	1.74e-05	0.000405	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—IFNA2—thyroid cancer	1.73e-05	0.000401	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—TPR—thyroid cancer	1.72e-05	0.0004	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.72e-05	0.000399	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PRKAR1A—thyroid cancer	1.71e-05	0.000398	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PRKAR1A—thyroid cancer	1.7e-05	0.000394	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—HPGD—thyroid cancer	1.68e-05	0.00039	CbGpPWpGaD
Zidovudine—TERT—Disease—HRAS—thyroid cancer	1.65e-05	0.000384	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—HPGD—thyroid cancer	1.64e-05	0.000381	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—RXRA—thyroid cancer	1.59e-05	0.000369	CbGpPWpGaD
Zidovudine—SLC22A2—Transmission across Chemical Synapses—HRAS—thyroid cancer	1.59e-05	0.000369	CbGpPWpGaD
Zidovudine—ABCC5—Disease—BRAF—thyroid cancer	1.58e-05	0.000368	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—TPR—thyroid cancer	1.58e-05	0.000368	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—NRAS—thyroid cancer	1.58e-05	0.000367	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.58e-05	0.000367	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—MINPP1—thyroid cancer	1.57e-05	0.000364	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	1.56e-05	0.000362	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—HPGD—thyroid cancer	1.53e-05	0.000356	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.53e-05	0.000355	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.52e-05	0.000353	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.51e-05	0.00035	CbGpPWpGaD
Zidovudine—TERT—Disease—AKT1—thyroid cancer	1.46e-05	0.000339	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.44e-05	0.000335	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.43e-05	0.000332	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—NRAS—thyroid cancer	1.42e-05	0.000331	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.38e-05	0.00032	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.36e-05	0.000316	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—KRAS—thyroid cancer	1.36e-05	0.000316	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PPARG—thyroid cancer	1.36e-05	0.000316	CbGpPWpGaD
Zidovudine—TK1—Metabolism—AKT1—thyroid cancer	1.35e-05	0.000314	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.33e-05	0.00031	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—SLC5A5—thyroid cancer	1.3e-05	0.000303	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—SLC5A5—thyroid cancer	1.29e-05	0.0003	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PTGS2—thyroid cancer	1.28e-05	0.000297	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.26e-05	0.000294	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CHST14—thyroid cancer	1.25e-05	0.000291	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.24e-05	0.000289	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—KRAS—thyroid cancer	1.23e-05	0.000285	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—HRAS—thyroid cancer	1.22e-05	0.000283	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TP53—thyroid cancer	1.21e-05	0.000281	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—SLC5A5—thyroid cancer	1.18e-05	0.000275	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—HRAS—thyroid cancer	1.16e-05	0.000269	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PTEN—thyroid cancer	1.12e-05	0.000259	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—RXRA—thyroid cancer	1.1e-05	0.000254	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TP53—thyroid cancer	1.09e-05	0.000253	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—RXRA—thyroid cancer	1.08e-05	0.000252	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—TPR—thyroid cancer	1.08e-05	0.000251	CbGpPWpGaD
Zidovudine—ALB—Metabolism—TPR—thyroid cancer	1.08e-05	0.00025	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PTGS2—thyroid cancer	1.07e-05	0.000249	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.06e-05	0.000247	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.06e-05	0.000246	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PRKAR1A—thyroid cancer	1.06e-05	0.000246	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—HRAS—thyroid cancer	1.04e-05	0.000242	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—AKT1—thyroid cancer	1.02e-05	0.000237	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—HPGD—thyroid cancer	1.01e-05	0.000235	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PPARG—thyroid cancer	1e-05	0.000233	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—RXRA—thyroid cancer	9.96e-06	0.000231	CbGpPWpGaD
Zidovudine—ABCC5—Disease—NRAS—thyroid cancer	9.95e-06	0.000231	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—TPR—thyroid cancer	9.65e-06	0.000224	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.64e-06	0.000224	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.59e-06	0.000223	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	9.5e-06	0.00022	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—TPR—thyroid cancer	9.42e-06	0.000219	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	9.42e-06	0.000219	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PTEN—thyroid cancer	9.34e-06	0.000217	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	9.27e-06	0.000215	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—AKT1—thyroid cancer	9.2e-06	0.000214	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—TPR—thyroid cancer	8.8e-06	0.000204	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	8.66e-06	0.000201	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.61e-06	0.0002	CbGpPWpGaD
Zidovudine—ABCC5—Disease—KRAS—thyroid cancer	8.56e-06	0.000199	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—SLC5A5—thyroid cancer	8.09e-06	0.000188	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	8.08e-06	0.000188	CbGpPWpGaD
Zidovudine—ALB—Metabolism—SLC5A5—thyroid cancer	8.05e-06	0.000187	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	7.95e-06	0.000185	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PTGS2—thyroid cancer	7.89e-06	0.000183	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	7.85e-06	0.000182	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.58e-06	0.000176	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.54e-06	0.000175	CbGpPWpGaD
Zidovudine—ABCC5—Disease—HRAS—thyroid cancer	7.28e-06	0.000169	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—SLC5A5—thyroid cancer	7.22e-06	0.000168	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—SLC5A5—thyroid cancer	7.05e-06	0.000164	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PPARG—thyroid cancer	6.92e-06	0.000161	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PTEN—thyroid cancer	6.88e-06	0.00016	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PPARG—thyroid cancer	6.85e-06	0.000159	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—RXRA—thyroid cancer	6.8e-06	0.000158	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.77e-06	0.000157	CbGpPWpGaD
Zidovudine—ALB—Metabolism—RXRA—thyroid cancer	6.76e-06	0.000157	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.61e-06	0.000154	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—SLC5A5—thyroid cancer	6.59e-06	0.000153	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.58e-06	0.000153	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—NRAS—thyroid cancer	6.45e-06	0.00015	CbGpPWpGaD
Zidovudine—ABCC5—Disease—AKT1—thyroid cancer	6.43e-06	0.000149	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PPARG—thyroid cancer	6.29e-06	0.000146	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.17e-06	0.000143	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—RXRA—thyroid cancer	6.07e-06	0.000141	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—RXRA—thyroid cancer	5.92e-06	0.000138	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.9e-06	0.000137	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—TPR—thyroid cancer	5.8e-06	0.000135	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	5.71e-06	0.000133	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—KRAS—thyroid cancer	5.55e-06	0.000129	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—RXRA—thyroid cancer	5.53e-06	0.000129	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTGS2—thyroid cancer	5.44e-06	0.000126	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTGS2—thyroid cancer	5.39e-06	0.000125	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.38e-06	0.000125	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—AKT1—thyroid cancer	5.38e-06	0.000125	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTGS2—thyroid cancer	4.95e-06	0.000115	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—thyroid cancer	4.93e-06	0.000114	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTEN—thyroid cancer	4.75e-06	0.00011	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—HRAS—thyroid cancer	4.72e-06	0.000109	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTEN—thyroid cancer	4.7e-06	0.000109	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	4.34e-06	0.000101	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTEN—thyroid cancer	4.31e-06	0.0001	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PPARG—thyroid cancer	4.29e-06	9.97e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PPARG—thyroid cancer	4.27e-06	9.91e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—AKT1—thyroid cancer	4.16e-06	9.67e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—AKT1—thyroid cancer	3.97e-06	9.21e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PPARG—thyroid cancer	3.83e-06	8.9e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PPARG—thyroid cancer	3.74e-06	8.69e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—RXRA—thyroid cancer	3.65e-06	8.48e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PPARG—thyroid cancer	3.49e-06	8.11e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTGS2—thyroid cancer	3.38e-06	7.84e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTGS2—thyroid cancer	3.36e-06	7.8e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTGS2—thyroid cancer	3.02e-06	7e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTEN—thyroid cancer	2.95e-06	6.84e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTGS2—thyroid cancer	2.94e-06	6.83e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTEN—thyroid cancer	2.93e-06	6.8e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTGS2—thyroid cancer	2.75e-06	6.38e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—AKT1—thyroid cancer	2.74e-06	6.35e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—AKT1—thyroid cancer	2.71e-06	6.29e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTEN—thyroid cancer	2.63e-06	6.11e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTEN—thyroid cancer	2.57e-06	5.96e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—AKT1—thyroid cancer	2.49e-06	5.77e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTEN—thyroid cancer	2.4e-06	5.57e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PPARG—thyroid cancer	2.3e-06	5.35e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.81e-06	4.21e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—AKT1—thyroid cancer	1.7e-06	3.94e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—AKT1—thyroid cancer	1.69e-06	3.92e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTEN—thyroid cancer	1.58e-06	3.67e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—AKT1—thyroid cancer	1.52e-06	3.52e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—AKT1—thyroid cancer	1.48e-06	3.43e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—AKT1—thyroid cancer	1.38e-06	3.21e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—AKT1—thyroid cancer	9.11e-07	2.12e-05	CbGpPWpGaD
